2mg Tirzepatide: Understanding the Starting Dose Decision

What you're actually deciding when you ask about the 2mg dose

Most people land on this question for one of two reasons: they've seen a 2mg figure listed on an overseas or compounded product, or they want to understand how low the treatment starts before committing to a consultation. Both are reasonable things to check. The honest answer is that 2mg sits outside the licensed UK Mounjaro range entirely. The schedule runs 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. If a seller is offering a 2mg tirzepatide product, that product is either mislabelled, compounded without a UK licence, or sourced outside the regulated supply chain, none of which are safe routes for a prescription-only medicine.

The 2.5mg starter dose exists for a reason grounded in tolerability, not caution for caution's sake. Tirzepatide slows gastric emptying and changes how the gut signals fullness to the brain, and those effects need a settling-in period. Starting low reduces the likelihood of nausea, vomiting and other gastrointestinal side effects that are most common in the early weeks. Your prescriber manages that titration, the timing of each step up is a clinical judgement, not something to self-direct. The NHS tirzepatide medicines page covers the licensed dose schedule and what to expect at each stage.

The decision this page helps you make is simpler than it might look: if you've found a 2mg product, look harder at the source before you proceed. If you're researching how the treatment begins, the 2.5mg starting point is the right frame of reference, and understanding the full dose range up to 30mg helps put that first step in context.

Why compounded or unlicensed tirzepatide is a different risk category

A question our prescribers hear most weeks is some version of: "I found tirzepatide much cheaper online, is it the same thing?" Sometimes those products are described in doses that don't match any licensed Mounjaro pen, including 2mg. The short answer is that compounded tirzepatide (produced by unlicensed facilities, often overseas) bypasses every quality check that applies to the licensed supply chain. It is not manufactured to the same purity standards, may contain incorrect concentrations, and has no MHRA oversight.

The MHRA's public warnings have been direct: fake and unlicensed weight-loss injections have been seized in significant quantities across the UK, including a 2025 raid on an unlicensed domestic manufacturing site producing counterfeit tirzepatide pens. Some seized products have contained entirely different active substances. For a medicine administered by injection, the consequences of an incorrect active ingredient or concentration can be serious. If you are uncertain whether a product is genuinely licensed, our guide to Mounjaro or tirzepatide explains the relationship between the brand name and the active substance, which can help you identify whether what you have been offered matches the regulated supply chain. The safest way to check any online pharmacy is to look it up on the GPhC pharmacy register before purchasing.

If you come across a seller offering tirzepatide in doses, formats or prices that don't match the licensed Mounjaro range, that mismatch is itself a warning sign worth taking seriously. You can report suspect sellers directly at the MHRA's Yellow Card scheme.

Who the licensed 2.5mg starting dose is intended for

Licensed tirzepatide is indicated for adults managing weight alongside a reduced-calorie diet and increased physical activity. The private eligibility thresholds follow the Mounjaro SmPC: a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone is never the whole picture, a prescriber weighs your full medical history, current medicines and individual circumstances before prescribing.

On the NHS, tirzepatide access is currently phased and more restrictive; NICE's appraisal of tirzepatide (TA1026) sets out the criteria, which are being expanded in stages through to 2027. Many people who qualify on clinical grounds still face a wait or do not yet meet the NHS threshold for their phase. Private prescribing through a regulated pharmacy is one way to access treatment without a referral or a waiting list, provided you meet the clinical criteria. You can read a broader overview of how tirzepatide works as a treatment to get the full picture before making a decision, or compare it with the other licensed option via our weight-loss treatments overview.

If you want to understand how Mounjaro specifically is structured as a branded product, our Mounjaro guide covers the pen, the schedule and what to expect month by month. For questions about cost as a private patient, the Mounjaro price comparison page sets out what private treatment typically costs and what any legitimate price should include.

What to do if you're ready to explore the licensed route

If the licensed 2.5mg tirzepatide schedule is what you're looking for, the route begins with a clinical consultation. At nume, that consultation is free and reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician reads your answers, not an automated queue. Identity and weight are verified on video. If treatment is clinically suitable and your order is placed before 12pm Monday to Friday, your prescription is dispatched the same day and delivered free the next working day by DPD, in plain unbranded packaging.

There are no subscriptions and no hidden fees. The price shown on the treatment page covers the consultation, prescription, the medicine and delivery. Every repeat order goes through the same clinical review before dispatch. Our about page explains how the pharmacy is structured and regulated, and our clinical team profile introduces the prescribers overseeing your care. If you have specific questions before starting, our FAQs cover the most common ones, or you can reach the team directly.

The starting-dose decision, once you're in the licensed system, is made with your prescriber. That first 2.5mg pen is adjustment, not treatment in miniature, and reading about tirzepatide l helps clarify what that initial phase involves and how the medicine is used across the full course. Worth knowing before you begin. Start your free consultation and let a prescriber assess whether tirzepatide is the right fit for you.